Skip to main content
. 2020 Sep 16;12(9):e10491. doi: 10.7759/cureus.10491

Table 4. Results of subgroup analyses for IH at the six-month and one-year follow-ups.

All outcomes are stratified according to study design (RCTs or observational), mesh location (onlay, retrorectus, preperitoneal, and intraperitoneal), mean BMI (<40 and >40), and study population (bariatric, neoplastic, vascular, and mixed). The value of I2 shows the heterogeneity among subgroups.

Psubgroup represents p-values between subgroups.

IH, incisional hernia; OR, odds ratio; No Sig. Diff., no significant difference; Sig. Diff., Significant difference.

Subgroups IH at 6-months follow-up IH at 1-year follow-up
  N studies I2 (%) OR [95% CI] Psubgroup Comments N studies I2 (%) OR [95% CI] Psubgroup Comments
Study design
RCT 2 0 1.26 [0.55, 2.91] 0.49 No Sig. Diff. 5 86 0.14 [0.03, 0.82] 0.70 No Sig. Diff.
Observational 1 - 0.43 [0.02, 8.34] 3 0 0.21 [0.08, 0.59]
Mesh location
Onlay 1 - 0.43 [0.02, 8.34] 0.49 No Sig. Diff. 3 50 0.13 [0.03, 0.52] 0.28 No Sig. Diff.
Retrorectus - - - 2 0 0.07 [0.01, 0.38]
Preperitoneal 2 0 1.26 [0.55, 2.91] 2 59 0.60 [0.11, 3.14]
Intraperitoneal - - - 1 - 0.10 [0.02, 0.47]
Mean BMI
<40 1 - 0.43 [0.02, 8.34] 0.49 No Sig. Diff. 2 0 0.08 [0.02, 0.32] 0.11 No Sig. Diff.
>40 2 0 1.26 [0.55, 2.91] 5 60 0.33 [0.11, 1.00]
Study population
Bariatric 2 0 1.26 [0.55, 2.91] 0.49 No Sig. Diff. 4 63 0.30 [0.07, 1.36] 0.58 No Sig. Diff.
Neoplastic - - - 2 75 0.12 [0.02, 0.81]
Vascular - - - 1 - 0.04 [0.00, 0.72]
Mixed 1 - 0.43 [0.02, 8.34] 1 - 0.10 [0.02, 0.47]